Aura raises $30M series C

Aura Biosciences Inc. (Cambridge, Mass.) raised $30 million in a series C round led by new investors Lundbeckfonden Ventures and Arix Bioscience plc. Existing investors also participated, including Advent Life Sciences, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments, Columbus Venture Partners, LI-COR Biosciences and the estate of Henri Termeer. ...